These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16136574)

  • 1. Comparison of pharmacokinetics of loxoprofen and its active metabolites after an intravenous, intramuscular, and oral administration of loxoprofen in rats: evidence for extrahepatic metabolism.
    Koo TS; Kim DH; Ahn SH; Kim KP; Kim IW; Seo SY; Suh YG; Kim DD; Shim CK; Chung SJ
    J Pharm Sci; 2005 Oct; 94(10):2187-97. PubMed ID: 16136574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of loxoprofen and its active metabolite after dermal application of loxoprofen gel to rats.
    Sawamura R; Kazui M; Kurihara A; Izumi T
    Pharmazie; 2015 Feb; 70(2):74-80. PubMed ID: 25997245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of sulfonyl-loxoprofen as novel phase 2 conjugate in rat.
    Shrestha R; Paudel S; Cho P; Shrestha A; Jeong TC; Lee ES; Lee T; Lee S
    Biopharm Drug Dispos; 2019 Jul; 40(7):234-241. PubMed ID: 31242324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered metabolism of orally administered loxoprofen in human subjects after an oral administration of loxoprofen for three consecutive days followed by a seven-day washout.
    Kim IW; Chung SJ; Shim CK
    J Pharm Sci; 2002 Apr; 91(4):973-9. PubMed ID: 11948535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pharmacokinetics between loxoprofen and its derivative with lower ulcerogenic activity, fluoro-loxoprofen.
    Yamakawa N; Suemasu S; Watanabe H; Tahara K; Tanaka K; Okamoto Y; Ohtsuka M; Maruyama T; Mizushima T
    Drug Metab Pharmacokinet; 2013; 28(2):118-24. PubMed ID: 22892443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the route of administration on the pharmacokinetics of pirprofen enantiomers in the rat.
    Brocks DR; Liang WT; Jamali F
    Chirality; 1993; 5(2):61-4. PubMed ID: 8343343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased oral bioavailability of loxoprofen at second administration in human subjects.
    Kim IW; Choo KS; Han TG; Kim KS; Chung SJ; Lee MH; Shim CK
    Int J Clin Pharmacol Ther; 2000 Jan; 38(1):10-4. PubMed ID: 10667831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and simultaneous analysis of loxoprofen and its diastereometric alcohol metabolites in human serum by on-line column switching liquid chromatography and its application to a pharmacokinetic study.
    Cho HY; Park CH; Lee YB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):27-34. PubMed ID: 16563885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of antibody-mediated extraction for the stereoselective determination of the active metabolite of loxoprofen in human and rat plasma.
    Takasaki W; Tanaka Y
    Chirality; 1992; 4(5):308-15. PubMed ID: 1503853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution, metabolism and excretion of loxoprofen after dermal application of loxoprofen gel to rats.
    Sawamura R; Kazui M; Kurihara A; Izumi T
    Xenobiotica; 2014 Nov; 44(11):1026-38. PubMed ID: 24916900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the disposition of a novel p38 MAPK inhibitor, AKP-001, and its metabolites in rats with a simple physiologically based pharmacokinetic model.
    Shirota K; Kaneko M; Sasaki M; Minato K; Fujikata A; Ohta S; Hisaka A; Suzuki H
    Drug Metab Dispos; 2015 Feb; 43(2):217-26. PubMed ID: 25422274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bioequivalence study of two brands of loxoprofen tablets in healthy volunteers.
    Jhee OH; Lee MH; Shaw LM; Lee SE; Park JH; Kang JS
    Arzneimittelforschung; 2007; 57(8):542-6. PubMed ID: 17915642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic determination of loxoprofen and its diastereomeric alcohol metabolites in biological fluids by fluorescence labelling with 4-bromomethyl-6,7-methylenedioxycoumarin.
    Naganuma H; Kawahara Y
    J Chromatogr; 1990 Sep; 530(2):387-96. PubMed ID: 2079513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the individual enantiomer S-(+)-ketoprofen after intravenous and oral administration in dogs at two dose levels.
    Serrano-Rodríguez JM; Serrano JM; Rodríguez JM; Machuca MM; Gómez-Villamandos RJ; Navarrete-Calvo R
    Res Vet Sci; 2014 Jun; 96(3):523-5. PubMed ID: 24746290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereospecificity of enzymatic hydrogen transfer to loxoprofen, a non-steroidal antiinflammatory agent, in the rat.
    Naganuma H; Kawahara Y
    Res Commun Chem Pathol Pharmacol; 1990 Aug; 69(2):173-85. PubMed ID: 2396045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
    J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of pirprofen and its pyrrol metabolite in elderly patients.
    Rossi FA; Ferrero M; Balladore GE; Zecca L; Fraschini F; Ferrario P; Bichisao E; Monza GC; Maresca V
    Eur J Clin Pharmacol; 1988; 35(4):379-83. PubMed ID: 3197745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of the diastereomers of arteether, a potent antimalarial drug, in rats.
    Sabarinath S; Madhusudanan KP; Gupta RC
    Biopharm Drug Dispos; 2005 Sep; 26(6):211-23. PubMed ID: 15926191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic profiles of the active metamizole metabolites after four different routes of administration in healthy dogs.
    Giorgi M; Łebkowska-Wieruszewska B; Lisowski A; Owen H; Poapolathep A; Kim TW; De Vito V
    J Vet Pharmacol Ther; 2018 Jun; 41(3):428-436. PubMed ID: 29352476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.